Energy requirement for the formation of blender-resistant complexes in Lactobacillus phage infection.
D000327:Adsorption; D001151:Arsenic / Q000494:pharmacology; D001386:Azides / Q000494:pharmacology; D001435:Bacteriophages / Q000254:growth & development* / Q000378:metabolism; D002701:Chloramphenicol / Q000494:pharmacology; D003486:Cyanides / Q000494:pharmacology; D001728:Dicumarol / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D004734:Energy Metabolism; D005463:Fluoroacetates / Q000494:pharmacology; D006096:Gramicidin / Q000494:pharmacology; D007780:Lacticaseibacillus casei / Q000378:metabolism*; D010416:Pentachlorophenol / Q000494:pharmacology; D012367:RNA, Viral / Q000378:metabolism; D013696:Temperature
D001386:Azides; D003486:Cyanides; D004140:Dinitrophenols; D005463:Fluoroacetates; D012367:RNA, Viral; D006096:Gramicidin; D002701:Chloramphenicol; D001728:Dicumarol; D010416:Pentachlorophenol; D001151:Arsenic